Charles River Laboratories Schedules Third-Quarter 2023 Earnings Release and Conference Call
16 Outubro 2023 - 9:30AM
Business Wire
Charles River Laboratories International, Inc. (NYSE: CRL) will
release third-quarter 2023 financial results on Wednesday, November
8th, before the market opens. A conference call has been scheduled
to discuss this information on Wednesday, November 8th, at 8:30
a.m. ET.
Investors will have the opportunity to listen to a live webcast
of the conference call through the Investor Relations section of
the Company's website at ir.criver.com. A replay will be accessible
through the same website.
About Charles River
Charles River provides essential products and services to help
pharmaceutical and biotechnology companies, government agencies and
leading academic institutions around the globe accelerate their
research and drug development efforts. Our dedicated employees are
focused on providing clients with exactly what they need to improve
and expedite the discovery, early-stage development and safe
manufacture of new therapies for the patients who need them. To
learn more about our unique portfolio and breadth of services,
visit www.criver.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231016071073/en/
Investor Relations Contact: Todd Spencer Corporate Vice
President, Investor Relations 781.222.6455 todd.spencer@crl.com
Charles River Laboratories (NYSE:CRL)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Charles River Laboratories (NYSE:CRL)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024